292 related articles for article (PubMed ID: 34269079)
21. Complex in vitro Model: A Transformative Model in Drug Development and Precision Medicine.
Wang L; Hu D; Xu J; Hu J; Wang Y
Clin Transl Sci; 2023 Dec; 17(2):. PubMed ID: 38062923
[TBL] [Abstract][Full Text] [Related]
22. The application of engineered liver tissues for novel drug discovery.
Lin C; Ballinger KR; Khetani SR
Expert Opin Drug Discov; 2015 May; 10(5):519-40. PubMed ID: 25840592
[TBL] [Abstract][Full Text] [Related]
23. Next generation human skin constructs as advanced tools for drug development.
Abaci HE; Guo Z; Doucet Y; Jacków J; Christiano A
Exp Biol Med (Maywood); 2017 Nov; 242(17):1657-1668. PubMed ID: 28592171
[TBL] [Abstract][Full Text] [Related]
24. Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening.
Nam KH; Smith AS; Lone S; Kwon S; Kim DH
J Lab Autom; 2015 Jun; 20(3):201-15. PubMed ID: 25385716
[TBL] [Abstract][Full Text] [Related]
25. 3D Bioprinting of Tissue/Organ Models.
Pati F; Gantelius J; Svahn HA
Angew Chem Int Ed Engl; 2016 Apr; 55(15):4650-65. PubMed ID: 26895542
[TBL] [Abstract][Full Text] [Related]
26. Reconstituted Human Organ Models as a Translational Tool for Human Organ Response: Definition, Expectations, Cases, and Strategies for Implementation in Drug Discovery and Development.
Tetsuka K; Ohbuchi M; Kawabe T; Goto T; Kiyonaga F; Takama K; Yamazaki S; Fujimori A
Biol Pharm Bull; 2020; 43(3):375-383. PubMed ID: 32115499
[TBL] [Abstract][Full Text] [Related]
27. Engineered Muscle Tissues for Disease Modeling and Drug Screening Applications.
Mohammadi MH; Obregón R; Ahadian S; Ramón-Azcón J; Radisic M
Curr Pharm Des; 2017; 23(20):2991-3004. PubMed ID: 28215153
[TBL] [Abstract][Full Text] [Related]
28. Automation of a phospho-STAT5 staining procedure for flow cytometry for application in drug discovery.
Malergue F; van Agthoven A; Scifo C; Egan D; Strous GJ
J Biomol Screen; 2015 Mar; 20(3):416-21. PubMed ID: 25325258
[TBL] [Abstract][Full Text] [Related]
29. Academic collaborative models fostering the translation of physiological in vitro systems from basic research into drug discovery.
Silvestri A; Vicente F; Vicent MJ; Stechmann B; Fecke W
Drug Discov Today; 2021 Jun; 26(6):1369-1381. PubMed ID: 33677144
[TBL] [Abstract][Full Text] [Related]
30. MyoScreen, a High-Throughput Phenotypic Screening Platform Enabling Muscle Drug Discovery.
Young J; Margaron Y; Fernandes M; Duchemin-Pelletier E; Michaud J; Flaender M; Lorintiu O; Degot S; Poydenot P
SLAS Discov; 2018 Sep; 23(8):790-806. PubMed ID: 29498891
[TBL] [Abstract][Full Text] [Related]
31. In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening.
Antunes J; Gaspar VM; Ferreira L; Monteiro M; Henrique R; Jerónimo C; Mano JF
Acta Biomater; 2019 Aug; 94():392-409. PubMed ID: 31200118
[TBL] [Abstract][Full Text] [Related]
32. A hydrogel bioink toolkit for mimicking native tissue biochemical and mechanical properties in bioprinted tissue constructs.
Skardal A; Devarasetty M; Kang HW; Mead I; Bishop C; Shupe T; Lee SJ; Jackson J; Yoo J; Soker S; Atala A
Acta Biomater; 2015 Oct; 25():24-34. PubMed ID: 26210285
[TBL] [Abstract][Full Text] [Related]
33. Converging functionality: Strategies for 3D hybrid-construct biofabrication and the role of composite biomaterials for skeletal regeneration.
Alcala-Orozco CR; Cui X; Hooper GJ; Lim KS; Woodfield TBF
Acta Biomater; 2021 Sep; 132():188-216. PubMed ID: 33713862
[TBL] [Abstract][Full Text] [Related]
34. Label-free screening assays: a strategy for finding better drug candidates.
Lunn CA
Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
[TBL] [Abstract][Full Text] [Related]
35. Microengineered Organ-on-a-chip Platforms towards Personalized Medicine.
Kankala RK; Wang SB; Chen AZ
Curr Pharm Des; 2018; 24(45):5354-5366. PubMed ID: 30799783
[TBL] [Abstract][Full Text] [Related]
36. Engineering kidney tissues for polycystic kidney disease modeling and drug discovery.
Brizi V; Benedetti V; Lavecchia AM; Xinaris C
Methods Cell Biol; 2019; 153():113-132. PubMed ID: 31395375
[TBL] [Abstract][Full Text] [Related]
37. 3D Miniaturization of Human Organs for Drug Discovery.
Park J; Wetzel I; Dréau D; Cho H
Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 28885786
[TBL] [Abstract][Full Text] [Related]
38. Biofabricated constructs as tissue models: a short review.
Costa PF
J Mater Sci Mater Med; 2015 Apr; 26(4):156. PubMed ID: 25779513
[TBL] [Abstract][Full Text] [Related]
39. Tissue-engineered heart chambers as a platform technology for drug discovery and disease modeling.
Mousavi A; Stefanek E; Jafari A; Ajji Z; Naghieh S; Akbari M; Savoji H
Biomater Adv; 2022 Jul; 138():212916. PubMed ID: 35913255
[TBL] [Abstract][Full Text] [Related]
40. Advanced Multi-Dimensional Cellular Models as Emerging Reality to Reproduce
Bassi G; Grimaudo MA; Panseri S; Montesi M
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
